Beximco Pharmaceuticals (BXP) Stock Chart & Stock Price History GBX 44.61 -1.89 (-4.07%) As of 07:58 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesBuy This Stock Beximco Pharmaceuticals Stock Price Performance The Beximco Pharmaceuticals (BXP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 86.01%, with a year-to-date return of 16.77%. In the past month, the stock has decreased 10.79%, reflecting recent market activity. As of the latest close, Beximco Pharmaceuticals traded at GBX 45.50 with a market cap of £202.98 million and volume of 146,505 shares. Five years ago, the stock traded at GBX 53.50, representing a 16.62% decrease over that period. At the time, it had a market cap of £216.97 million and a volume of 43,808 shares. Receive BXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-5.32%1 Month Performance-10.79%3 Month Performance+26.26%Year-To-Date Performance+16.77%1 Year Performance+86.01%5 Year Performance-16.62% BXP Stock Chart for Friday, September, 26, 2025 BXP Chart by TradingView Beximco Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/25/2025GBX 46.50GBX 45.50-2.15%GBX 46.50GBX 45.50146,505 shs£202.98 million09/24/2025GBX 45.50GBX 46.50+2.20%GBX 46.50GBX 45.09785,400 shs£207.44 million09/23/2025GBX 45GBX 45.50+1.11%GBX 46.35GBX 45.4560,775 shs£202.98 million09/22/2025GBX 47.11GBX 45-4.48%GBX 45.88GBX 4539,870 shs£200.75 million09/19/2025GBX 47.14GBX 47.11-0.06%GBX 47.11GBX 46.208,935 shs£210.16 million09/18/2025GBX 47.40GBX 47.14-0.55%GBX 47.14GBX 46.5022,015 shs£210.30 million09/17/2025GBX 47.40GBX 47.40GBX 47.48GBX 45.6247,212 shs£211.46 million09/16/2025GBX 47.40GBX 47.40GBX 47.40GBX 4515,786 shs£211.46 million09/15/2025GBX 46.50GBX 47.40+1.94%GBX 48GBX 46.6029,877 shs£211.46 million09/12/2025GBX 45GBX 45GBX 47.55GBX 4512,951 shs£200.75 million Get the Latest News and Ratings for BXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 09/11/2025GBX 45.45GBX 45-0.99%GBX 47.55GBX 4512,951 shs£200.75 million09/10/2025GBX 48GBX 45.45-5.31%GBX 46.50GBX 45.453,953 shs£202.76 million09/09/2025GBX 48GBX 48GBX 48GBX 46.501,500 shs£214.13 million09/08/2025GBX 45.62GBX 48+5.22%GBX 48GBX 46.501,500 shs£214.13 million09/05/2025GBX 46.50GBX 45.62-1.89%GBX 46.50GBX 45.626,165 shs£203.52 million09/04/2025GBX 46.50GBX 46.50GBX 48GBX 45.5650,480 shs£207.44 million09/03/2025GBX 46.87GBX 46.50-0.79%GBX 48GBX 45.5650,480 shs£207.44 million09/02/2025GBX 48GBX 46.87-2.35%GBX 46.87GBX 46.501,000 shs£209.09 million09/01/2025GBX 46.87GBX 48+2.41%GBX 48GBX 46.5080,000 shs£214.13 million08/29/2025GBX 46.11GBX 46.87+1.65%GBX 48GBX 46.1683,699 shs£31.95 billion08/28/2025GBX 48.67GBX 46.11-5.25%GBX 50.50GBX 46.1169,296 shs£31.43 billion08/27/2025GBX 50GBX 48.67-2.67%GBX 51.89GBX 48.6729,847 shs£33.17 billion08/26/2025GBX 49.60GBX 50+0.81%GBX 52.33GBX 5029,275 shs£34.08 billion08/25/2025GBX 49.60GBX 49.60GBX 50GBX 49.606,942 shs£33.81 billion Related Companies Molten Ventures Stock Chart Pinewood Technologies Group Stock Chart Prs Reit Stock Chart Saga Stock Chart Aurora Investment Trust Stock Chart Triple Point Social Housing REIT Stock Chart AdvancedAdvT Stock Chart Celtic Stock Chart Value and Indexed Property Income Stock Chart Corero Network Security Stock Chart Receive BXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:BXP) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredNew Buy Alert: Should you put $1,000 into Oracle (ORCL) now?Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle...Chaikin Analytics | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beximco Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Beximco Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
